Share this publication:
Closed loop insulin systems use a glucose sensor and insulin delivery system to maintain the blood glucose levels in an automated manner.These devices show great promise as a potential treatment option more importantly for Diabetes Mellitus Type 1 but also, Diabetes Mellitus Type 2. However these devices face many problems and these need to be solved before a truly clinically applicable form of the device is commercially introduced. Theirefficacy also needs to be improved in certain groups such as children and pregnant women.The literature search was done on two indexes, Google Scholar and PubMed, using mesh words ‘closed loop insulin delivery in diabetes’. All the publications, by various authors, returning to this search, were critically reviewed, assimilated and summarized.This article presents this summary of the problems faced by these devices and suggests possible solutions for their improvement.
About the publisher:
iMedPub Limited is a publishing house registered in UK, publishing medical books and journals since 2005. As an open service to doctors and biomedical researchers, it is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMedPub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMedPub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. As we are a low cost academic publisher we offer the lowest article processing charges of all biomedical journals and publish books free of charges for authors.